Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
213 Leser
Artikel bewerten:
(1)

MedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness

CLEARWATER, Fla., June 24, 2025 /PRNewswire/ -- MedWell Ai, Inc, (New Symbol/OTCQB: MWAI) is pleased to provide this Corporate Update, outlining company's new corporate branding and business direction.

Effective June 18, 2025, Integrated Ventures, Inc began trading as MedWellAi, Inc - rapidly growing and expanding AI-driven healthcare ecosystem, integrating e-commerce enterprise SaaS, group purchasing and distrubution, direct-to-consumer and corporate teleheath solutions.

Under new business direction, the Company will operate as portfolio company that develops, acquires, licenses technology and platforms with high growth potential, focused on Ai-driven healthcare and wellness solutions.

Company's business operations consist of:

  1. MedWell USA, LLC - B2B e-commerce ordering portal and distribution of pharma products for healthcare and wellness sectors, with focus on medical offices, wellness clinics, gyms and online telemedicine companies.
  2. TeleMD.Ai - Developer and operator of B2B/B2C telemedicine platform (under development) that connects consumers, corporations and its employees with licensed healthcare providers.
  3. MedWell Facilities, LLC - This subsidiary is focused on developing and managing (1) real estate opportunities, designed to attract health and wellness tenants and (2) Ai-driven software platform, designed to optimize the operational model for weight loss, wellness, IV therapies, aesthetics, and traditional healthcare clinics through licensing model.

MedWell Ai is pleased to disclose the following corporate developments:

  • New Corporate name: MedWell Ai, Inc.
  • New Corporate Website: www.medwellai.com.
  • New Trading Symbol: MWAI.
  • Launch of E-Commerce B2B Ordering Portal (wellness pharma) with over 80 products: www.medwellusa.com.
  • MedWell USA signed a Revenue Share Distribution Agreement with a licensed major pharmaceutical supplier.
  • MedWell USA executed Master Licensing Agreement ("MLA") with a AI software developer and technology partner to gain access to e-commerce ordering portal. This platform features tools for digital ordering, shipping, compliance automation, CRM management and real-time operational analytics.
  • Our MedWell Facilities has officially launched operations with Grand Opening of its first managed location via partnership with Giant Fitness Clubs, NJ (facility owner) and Driptide Wellness, NJ (tenant). Please visit www.driptide.com for additioinal information.

The Company's Management is please to provide this commentary:

"These corporate developments and agreements position MedWell Ai as major player in rapidly growing healtcare and wellness industry, while focusing on compliant pharmaceutical distribution and Ai driven digital healthcare and wellness innovation solutions. By leveraging AI automation, data-driven decision-making, and scalable SaaS platforms, MedWell Ai is building a next-generation healthcare infrastructure designed to support longevity and patient well-being. With an aggressive expansion strategy targeting direct-to-consumer subscribers, clinics, gyms and corporate clients, the Company is set to dominate the AI-driven healthcare and wellness space."

MedWell Ai for Wellness + Longevity. For Innovation + Scalable Growth.

For the Future of the Healthy America.

Safe Harbor Statement: The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

Contact: Steve Rubakh, CEO, [email protected]

SOURCE MedWellAi, Inc

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.